Article Information
History
- October 20, 2024.
Article Versions
- Version 1 (August 10, 2024 - 13:01).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Emily Groopman1,
- Shruthi Mohan2,
- Amber Waddell2,
- Matheus Wilke3,
- Raquel Fernandez4,
- Meredith Weaver4,
- Hongjie Chen5,
- Hongbin Liu6,
- Deeksha Bali7,
- Heather Baudet2,
- Lorne Clarke8,
- Christina Hung9,
- Rong Mao10,11,
- Filippo Pinto e Vairo3,
- Lemuel Racacho12,
- Tatiana Yuzyuk10,
- William J Craigen13 and
- Jennifer Goldstein2,*
- 1Children’s National Hospital, Washington, DC, USA
- 2Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- 3Mayo Clinic, Rochester, MN, USA
- 4American College of Genetics and Genomics, Bethesda, MD, USA
- 5PreventionGenetics/Exact Sciences, Marshfield, WI, USA
- 6Revvity, Pittsburgh, PA, USA
- 7Duke University Health System, Durham, NC, USA
- 8University of British Columbia, Vancouver, Canada
- 9LabCorp (formerly Invitae Corporation), San Francisco, CA, USA
- 10ARUP, Salt Lake City, UT, USA
- 11University of Utah, Salt Lake City, UT, USA
- 12Alberta Precision Laboratories, Alberta, Canada
- 13Baylor College of Medicine, Houston, TX, USA
- ↵*Corresponding author: Jennifer Goldstein, email address: jennifer.goldstein{at}unc.edu, Mailing address: Department of Genetics UNC-Chapel Hill CB#7264, Chapel Hill, NC 27599-7264
Posted October 20, 2024.
Assessment of genes involved in lysosomal diseases using the ClinGen Clinical Validity framework
